UA27048C2 - Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation - Google Patents

Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation

Info

Publication number
UA27048C2
UA27048C2 UA94020324A UA94020324A UA27048C2 UA 27048 C2 UA27048 C2 UA 27048C2 UA 94020324 A UA94020324 A UA 94020324A UA 94020324 A UA94020324 A UA 94020324A UA 27048 C2 UA27048 C2 UA 27048C2
Authority
UA
Ukraine
Prior art keywords
preparation
immunoreplacement
activity
basis
treatment
Prior art date
Application number
UA94020324A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Олександр Іванович Смикодуб
Александр Иванович Смыкодуб
Андрій Семенович Єфімов
Андрей Семенович Ефимов
Алла Володимирівна Новицька
Алла Владимировна Новицкая
Original Assignee
Центр Ембріональних Тканин "Емселл"
Центр эмбриональных тканей "ЭМСЕЛЛ"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Центр Ембріональних Тканин "Емселл", Центр эмбриональных тканей "ЭМСЕЛЛ" filed Critical Центр Ембріональних Тканин "Емселл"
Priority to UA94020324A priority Critical patent/UA27048C2/en
Priority to RU95120155/14A priority patent/RU2126260C1/en
Priority to PCT/UA1994/000025 priority patent/WO1995011659A2/en
Priority to NL9420012A priority patent/NL194693C/en
Priority to CA002152078A priority patent/CA2152078A1/en
Publication of UA27048C2 publication Critical patent/UA27048C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes

Abstract

The medicinal preparation of immunoreplacement activity on the basis of cellular suspension is prepared of the native or cryobanked hemopoietic cells of embryonic liver and/or spleen. The number of nucleacontaining cells in such suspension is from 5 to 900106/ml. The number of colony-forming units of granulomonocytic row is from 20 to 80/103/ml. The number of colony-forming units of blasts is from 0,5 to 9/103/ml. The number of early hemopoiesis precursors is from 1 to 9/106/ml.
UA94020324A 1993-10-18 1993-10-18 Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation UA27048C2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
UA94020324A UA27048C2 (en) 1993-10-18 1993-10-18 Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation
RU95120155/14A RU2126260C1 (en) 1993-10-18 1994-10-17 Cell suspension-based immunocorrecting drug and using this drug in a method of treating diabetes mellitus
PCT/UA1994/000025 WO1995011659A2 (en) 1993-10-18 1994-10-17 Pharmaceutical preparation with immuno-correcting properties based on a cell suspension, and a method of treating sugar diabetes using said preparation
NL9420012A NL194693C (en) 1993-10-18 1994-10-17 Method for the preparation of medicinal preparations for treating diabetes.
CA002152078A CA2152078A1 (en) 1993-10-18 1994-10-17 Pharmaceutical preparation with immuno-correcting properties based on a cell suspension, and a method of treating sugar diabetes using said preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA94020324A UA27048C2 (en) 1993-10-18 1993-10-18 Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation

Publications (1)

Publication Number Publication Date
UA27048C2 true UA27048C2 (en) 2000-02-28

Family

ID=21688946

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94020324A UA27048C2 (en) 1993-10-18 1993-10-18 Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation

Country Status (5)

Country Link
CA (1) CA2152078A1 (en)
NL (1) NL194693C (en)
RU (1) RU2126260C1 (en)
UA (1) UA27048C2 (en)
WO (1) WO1995011659A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2969899A (en) * 1998-12-16 2000-07-03 Tsentr Embrionalnykh Tkanei "Emcell" Method for treating patients using cellular suspensions of embryonic tissues
RU2160112C1 (en) * 2000-04-10 2000-12-10 Сухих Геннадий Тихонович Method for producing cellular transplant from fetus tissues
RU2007112288A (en) * 2007-04-03 2008-10-10 Александр Сергеевич Ботин (RU) COMPOSITION FOR STIMULATING GROWTH AND REGENERATION OF CELLS, AND ALSO WAY OF ITS PRODUCTION

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592637A (en) * 1978-03-22 1981-07-08 Parmer L P Lipid extract for inhibiting platelet function in blood
US4254103A (en) * 1979-06-08 1981-03-03 Institul de Cercetari Chimicofarmaceutice Hepatoprotector Factor (HF) and method of treatment
HU182087B (en) * 1980-01-15 1983-12-28 Mta Kiserleti Orvostudomanyi K Process for preparing an active substance for the selective inhibition of the multiplication of normal cells and of cells in myeloide leukemia
SU1158201A1 (en) * 1983-06-03 1985-05-30 Ленинградское Ордена Ленина,Ордена Трудового Красного Знамени Производственное Объединение Мясной Промышленности Им.С.М.Кирова Method of obtaining stimulator from mammalia spleen
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
IT1244879B (en) * 1990-12-11 1994-09-12 Alberto Bartorelli EXTRACTS FROM ANIMAL TISSUES, USEFUL IN THERAPY AND DIAGNOSTICS.

Also Published As

Publication number Publication date
NL9420012A (en) 1995-12-01
WO1995011659A2 (en) 1995-05-04
RU2126260C1 (en) 1999-02-20
NL194693B (en) 2002-08-01
NL194693C (en) 2002-12-03
WO1995011659A3 (en) 1995-06-01
CA2152078A1 (en) 1995-05-27

Similar Documents

Publication Publication Date Title
GB8922026D0 (en) Novel anti-viral and cytotoxic agent
CA2189250A1 (en) Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
CA2153584A1 (en) Cytokine restraining agents
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
IL93360A (en) Bactericidal/permeability increasing protein or biologically active analogs thereof and pharmaceutical compositions containing them
ES2010226A6 (en) Stable granulocyte colony stimulating factor composition
IE862543L (en) Pharmaceutical compositions
MX9603479A (en) 4-amino derivatives of mycophenolic acid with immunosuppressant activity.
CA2223433A1 (en) Ob protein compositions and methods
NZ219470A (en) Fungicidal compositions containing 3-cyano-4-(2,3 dichloro phenyl)-pyrrole
IL99145A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
EG18379A (en) Novel pharmacological compounds
EP1535929A3 (en) Megakaryocyte stimulating factors
IL99146A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
EP0340333A3 (en) Novel physiologically active polypeptide and pharmaceutical composition
HK1001004A1 (en) Bpc peptides their preparation and use
EP0286441A3 (en) Novel cytotoxic protein
KR880011198A (en) Cyclic Peptides and Methods for Making the Same
IL95391A0 (en) Substituted n-(quinolin-2-yl-methoxy)benzyl-sulphonyl-ureas,their preparation and pharmaceutical compositions containing them
ZA934037B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
HUT58765A (en) Process for producing peptide compounds and pharmaceutical compositions containing them as active components
CA2094275A1 (en) Methods and compositions for the treatment of cell proliferation disorders
IL95875A0 (en) Illudin analogs,pharmaceutical compositions containing the same and methods for the use thereof
MD1360C2 (en) A fungicidal composition, process for control and revention of plants Oomycetes infection
HUT46837A (en) Compositions of insectifuge and acarifuge activity containing alpha, omega-amino-alkohol derivatives as active components and process for producing the active components